RYAN QUARLESS: Open Payments
NPI 1528016797 · WINSTON-SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$183 in 9 payments from 7 companies in 2025. Trend: 2023 $384 · 2024 $280 · 2025 $183
Food & beverage: $183
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| GENZYME CORPORATION | 1 | $35 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $20 |
| Viatris Specialty LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: DUPIXENT, NUCALA, OFEV, ELIQUIS, YUPELRI, FASENRA.
Industry payments across NC — which companies pay providers there.
